Navigation Links
S.L.E. Lupus Foundation Gala Raises Record $3.2 Million for Lupus
Date:12/5/2007

Bob Costas Presents Award to NBC Sports Producer Michael Weisman and Wife

Carol

NEW YORK, Dec. 5 /PRNewswire/ -- The 2007 S.L.E. Lupus Foundation's "Life Without Lupus" Gala raised more than $3.2 million for lupus, a national record for funds collected at a single event to support education, provide services, and nurture research for the chronic and often devastating autoimmune illness. Nearly 700 supporters attended the December 3rd black tie event at the Marriott Marquis in New York's Times Square.

The evening's program was emceed by NBC's dynamic Today Show host, Hoda Kotb and featured a rousing 30-minute set by Broadway star and Tony Award winner, Patti LuPone. A dramatic video featuring people with lupus cast a reflective mood in the crowd as they assembled for dinner in the candlelit ballroom. (View video at http://www.LupusNY.org)

Sportscaster Bob Costas introduced the award to the Weismans, describing the couple as a "team in life and work." Carol Weisman, who has lupus, and husband Michael Weisman, an Emmy Award-winning producer for NBC Sports, connect generations, personalities, and East Coast to West Coast through their countless contributions to lupus.

In Los Angeles, Carol galvanized support for the Foundation's west coast division, Lupus LA, helping it to become the presence in patient awareness and Hollywood involvement that it is today. Now in New York, Carol is a dynamic voice on the Foundation's board of directors and a passionate advocate for its national research partner, the Lupus Research Institute.

With clear admiration for Carol and the multitude of others in the room that campaign for lupus, Mistress of Ceremonies Kotb described gathering similar courage to speak out about her recent fight with breast cancer following a comment from a stranger on an airplane flight: "Don't hog your journey," he advised her. Be a force for change. The Weismans, Kotb said, are a model for doing just that.

The 2007 Scientific Leadership Award was given to Benjamin Schwartz, MD, PhD, professor of internal medicine at Washington University in St. Louis, whose sage and steady guidance has enabled the Lupus Research Institute to pioneer a powerful model for scientific discovery in lupus.

The 2007 Corporate Leadership Award was given to Aspreva Pharmaceuticals, in recognition of its vigorous work in developing evidence-based treatments for people with lupus and other long-neglected diseases.

"The name Aspreva is derived from the words aspirations, hopes, and dreams," said Aspreva Executive Vice President of Global Pharmaceutical Operations, Rick Goulburn, upon accepting the award for the company. "We've been inspired by you to aspire hope and dream for a life without lupus," he said. "And due to your work, we'll hopefully get there in the not-too-distant future."

About the S.L.E. Lupus Foundation

The S.L.E. Lupus Foundation, headquartered in New York and Los Angeles, is the leading lupus organizations in the country providing patient services, education, public awareness and funding for novel lupus research. For more information on lupus or the Foundation, visit http://www.LupusNY.org.


'/>"/>
SOURCE S.L.E. Lupus Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Preclinical study suggests organ-transplant drug may aid in lupus fight
2. Genes Boost Risk for Rheumatoid Arthritis, Lupus
3. The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
4. Better Lupus Treatments on the Horizon
5. Stars Shine on Butterflies Over Hollywood for Lupus Foundation of America
6. Clinical Trials for Lupus Underway After Decades of Drought
7. October is Lupus Awareness Month
8. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
9. Photo: New York Goes Orange for Pumpkin Festival and Lupus Awareness Month
10. Mayo Clinic shows therapy effective for reducing lupus flares
11. Research suggests targeted treatment strategies for lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... ... the Snake”: an entertaining and moral-based short story about an unkind snake learning a ... Jr., a husband, father and grandfather who served as a U.S. Marine, U.S. Army ... for children and teens. My goal is to teach kids to use good judgement ...
(Date:8/17/2017)... NC (PRWEB) , ... August 17, 2017 , ... ... dental practice, is adding a new location in Goldsboro, NC to its family ... care that is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... series, proudly announces that it will feature the National Council for Therapeutic Recreation ... for more information. , Established in 1981, NCTRC is a non-profit, international organization ...
(Date:8/17/2017)... MA (PRWEB) , ... August 17, 2017 , ... ... will come together on September 19, 2017 for Anti-Infectives Rx. This off-the-record networking ... B. Martin Conference Center at Harvard Medical School. , Industry leaders and decision ...
(Date:8/17/2017)... GA (PRWEB) , ... August 17, 2017 , ... ... to welcome Dr. Kristi Hebert to its newest location in East ... enthusiastic to have Dr. Hebert come aboard,” said Dr. Mark A. Haber, Georgia Urology’s ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... Aug. 2, 2017   Marshall County Hospital in Benton, Kentucky ... the risk of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for ... kill deadly pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: